PO.TB04.06 · 肿瘤生物学
理解环境砷升高尿路上皮膀胱癌风险的机制
Understanding the mechanisms by which environmental arsenic elevates the risk of urothelial bladder cancer
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
饮用水中的砷(As)与多种恶性肿瘤风险升高相关,尤其是尿路上皮膀胱癌(UBC),但其潜在机制仍知之甚少。我们此前已证明斑马鱼拥有可收缩的膀胱,其特化的尿路上皮在结构和功能上与人类膀胱高度相似。我们及其他研究者进一步表明,斑马鱼的砷代谢与人类相似,且斑马鱼表达关键的砷代谢基因AS3MT和MTHFR。AS3MT对于将无机砷甲基化为毒性较低的代谢物至关重要,而MTHFR则是生成通用甲基供体SAM所必需的;这两个基因中低活性的SNP均与UBC风险升高相关。我们使用成年斑马鱼和人类细胞系,旨在研究砷如何影响膀胱尿路上皮并升高UBC风险。在一项为期28天的研究中,暴露于500 ppb As(III)的成年斑马鱼表现出砷诱导的增生和尿路上皮增厚的组织学证据。对砷暴露斑马鱼膀胱的Bulk RNA-seq揭示了包括MYC、mTOR和未折叠蛋白反应在内的癌症相关通路上调。单细胞RNA-seq进一步鉴定出雌性特异性的尿路上皮和非尿路上皮细胞簇,并揭示了砷所改变的、在两性间存在差异的独特细胞簇,提示这可能与已知的UBC性别偏倚相关。在雌性和雄性尿路上皮细胞簇中,砷均诱导细胞从UPK+表型向分化程度较低的UPK-表型转变。观察到包括UPK3B、KRT5和KRT15在内的腔面和基底标志物同时缺失,而FOXA1等谱系调控因子则得以保留。还观察到与促进肿瘤生长和侵袭相关的AP-1转录复合物的诱导。为进行验证,我们采用了自发永生化的人尿路上皮细胞系HBLAK。虽然HBLAK细胞呈均一的基底表型,但可通过抑制EGFR和激活PPARgamma诱导其表达腔面标志物,从而提供研究尿路上皮分化的平台。经诱导后,砷暴露的HBLAK细胞表现出基底标志物(KRT14)和腔面标志物(UPK2)的剂量依赖性减少,同时保留FOXA1表达,并伴有AP-1组分的上调,这与斑马鱼体内的发现一致。砷还诱导了组蛋白和DNA甲基化的整体缺失,并伴有SAM水平降低。我们将采用新构建的AS3MT和MTHFR敲除斑马鱼品系和人尿路上皮细胞系,以理解砷诱导的表观遗传失调及其与分化紊乱的关联。我们的研究结果确立了斑马鱼作为研究砷诱导尿路上皮分化改变的强大模型,并提示砷在斑马鱼和人类模型中均诱导尿路上皮细胞去分化,这可能导致肿瘤发生过程中肿瘤起始细胞的早期出现。
查看英文原文 English abstract
Arsenic (As) in drinking water is associated with increased risk of multiple malignancies, particularly urothelial bladder cancer (UBC), yet the underlying mechanisms remain poorly understood. We previously demonstrated that zebrafish possess a contractile urinary bladder with a specialized urothelium closely resembling the human bladder structurally and functionally. We and others have further shown that zebrafish As metabolism parallels that of humans and that zebrafish express the key As metabolism genes AS3MT and MTHFR. AS3MT is essential for methylating inorganic As into less toxic metabolites, while MTHFR is required for generating the universal methyl donor SAM; hypoactive SNPs in both genes are associated with increased UBC risk. Using both adult zebrafish and human cell lines, we aim to investigate how As impacts the bladder urothelium and elevates UBC risk. In a 28-day study, adult zebrafish exposed to 500 ppb As (III) exhibited histological evidence of As-induced hyperplasia and urothelial thickening. Bulk RNA-seq of As-exposed zebrafish bladders revealed upregulation of cancer-related pathways including MYC, mTOR, and unfolded protein response. Single cell RNA-seq further identified female-specific urothelial and non-urothelial clusters and revealed distinct clusters altered by As that differed between sexes, suggesting a potential link to the known sex bias in UBC. In both female and male urothelial clusters, As induced a shift of cells from a UPK+ phenotype to a less-differentiated UPK- phenotype. Loss of both luminal and basal markers including UPK3B, KRT5, and KRT15 was observed, while lineage-regulating factors like FOXA1 are retained. Induction of the AP-1 transcriptional complex, implicated in promoting tumor growth and invasion, was also observed. To validate, we employed the spontaneously immortalized human urothelial cell line HBLAK. While HBLAK cells are homogeneously basal, they can be induced with EGFR inhibition and PPARgamma activation to express luminal markers, providing a platform to study urothelial differentiation. Upon induction, As-exposed HBLAK cells exhibited a dose-dependent decrease in both basal (KRT14) and luminal (UPK2) markers while retaining FOXA1 expression, accompanied by upregulated AP-1 components, consistent with zebrafish in vivo findings. As also induced global loss of histone and DNA methylation, with reduced SAM levels. We will employ newly generated AS3MT and MTHFR knockout zebrafish lines and human urothelial cell lines to understand As-induced epigenetic dysregulation and its link to disrupted differentiation. Our findings establish zebrafish as a powerful model for studying As-induced changes in urothelial differentiation and suggest that As induces urothelial cell dedifferentiation in both zebrafish and human models, which may lead to the early emergence of tumor-initiating cells during tumorigenesis.
利益披露 Disclosure
Y. Huang, None..
B. C. Goodale, None..
J. E. Magurk, None..
X. Liu, None..
Y. Zheng, None..
S. A. Watts, None..
S. D. Leach, None.